SCHEMBL29537086

SCHEMBL29537086

CNc1ncc2c(n1)N1CCN=C1C(c1cc(N)ccc1Cl)=C2

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 5/20 0.39
▸ PTAFR P25105 3/20 0.34
▸ SRC P12931 3/20 0.34
▸ HCK P08631 2/20 0.34
▸ PTPN11 Q06124 1/20 0.33
▸ SIK1 P57059 4/20 0.32
▸ SIK2 Q9H0K1 4/20 0.32
▸ SIK3 Q9Y2K2 4/20 0.32
▸ MERTK Q12866 1/20 0.31
▸ PAK1 Q13153 1/20 0.31
▸ MAP4K4 O95819 1/20 0.30
▸ EED O75530 1/20 0.30
▸ DCAF15 Q66K64 1/20 0.30
▸ EGFR P00533 1/20 0.30
▸ FGFR1 P11362 1/20 0.30
▸ SMARCA2 P51531 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25422139 1.00 LCK (0.39) LCKPTAFRSRCHCKPTPN11
SCHEMBL29536566 0.89 LCK (0.33) LCKMAP4K4
SCHEMBL25421994 0.89 LCK (0.33) LCKMAP4K4
SCHEMBL26075409 0.87 LCK (0.33) LCKMAP4K4
SCHEMBL29536947 0.85 PSEN1 (0.33) LCKPTAFRSRCHCKPAK1
SCHEMBL26075195 0.85 PSEN1 (0.33) LCKPTAFRSRCHCKPAK1
SCHEMBL29536415 0.84 LCK (0.36) LCKPTAFRPAK1
SCHEMBL25421619 0.84 LCK (0.36) LCKPTAFRPAK1
SCHEMBL25421226 0.83 LCK (0.38) LCKPTAFRSRCHCKPTPN11
SCHEMBL29537336 0.83 LCK (0.38) LCKPTAFRSRCHCKPTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116710453-A Kinase inhibitors and uses thereof 璧辰医药技术股份有限公司 2023-09-05 — — CN disclosed
EP-4192582-A1 KINASE INHIBITORS AND USES THEREOF ABM Therapeutics Corporation (US) 2023-06-14 — — EP disclosed
WO-2022032071-A1 KINASE INHIBITORS AND USES THEREOF ABM THERAPEUTICS CORPORATION (US) 2022-02-10 — — WO disclosed
Send feedback